Company Profile

Carbonix LLC
Profile last edited on: 9/1/21      CAGE: 4XFN0      UEI:

Business Identifier: Sterilization processes and allergen removal: focus on removal of dust mites
Year Founded
2006
First Award
2010
Latest Award
2015
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1201 Main Street Suite 985
Columbia, SC 29201
   (559) 666-4837
   info@carbonix.org
   www.carbonix.org
Location: Single
Congr. District: 06
County: Richland

Public Profile

CarboNix LLC is an early stage, University of South Carolina-based startup commercializing technology licensed from the South Carolina Research Foundation involving removal of dust mites. The technology broadly pertains to use of cleaning and medical sterilization processes using a non-toxic, environmentally friendly sterilization technique that works at room temperature and without harsh chemicals. The company is focused on developing and commercializing a proprietary process whereby certain allergy causing substances can be denatured or deactivated. Laboratory results show that 80%-90% of offensive proteins can be denatured with a single sterilization/cleaning.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2015 2 NIH $1,113,316
Project Title: Allergens and Induced Asthma: Eradicating Indoor Allergens and Dust Mites
2010 1 NIH $128,748
Project Title: Deactivating Indoor Allergens Associated with Childhood Asthma

Key People / Management

  Allan M Quick -- Founder; CEO

  Michael A Matthews -- Chief Technology Officer

Company News

There are no news available.